These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7982368)

  • 41. Metered dose inhaler with spacer versus dry powder inhaler for delivery of salbutamol in acute exacerbations of asthma: a randomized controlled trial.
    Lodha R; Gupta G; Baruah BP; Nagpal R; Kabra SK
    Indian Pediatr; 2004 Jan; 41(1):15-20. PubMed ID: 14767083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma.
    Mazza JA; Tashkin DP; Reed CE
    Ann Allergy; 1992 Mar; 68(3):267-73. PubMed ID: 1532117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhaled beta-stimulants--a study of high-dose v. conventional-dose treatment in asthmatic outpatients.
    Bardin PG; Joubert JR
    S Afr Med J; 1991 Jun; 79(11):655-9. PubMed ID: 2047947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of a single dose of aerosol salbutamol and fenoterol/ipratropium on bronchial asthmatic patients.
    Filiz A; Ekinci E; Dikensoy O; Bulgur D; Oz M
    Del Med J; 1994 Oct; 66(10):549-52. PubMed ID: 7958119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic characteristics of a novel controlled-release sprinkle formulation of salbutamol.
    Mulligan S; Devane J; Martin M
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():312-4. PubMed ID: 1820899
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.
    Israel E; Chinchilli VM; Ford JG; Boushey HA; Cherniack R; Craig TJ; Deykin A; Fagan JK; Fahy JV; Fish J; Kraft M; Kunselman SJ; Lazarus SC; Lemanske RF; Liggett SB; Martin RJ; Mitra N; Peters SP; Silverman E; Sorkness CA; Szefler SJ; Wechsler ME; Weiss ST; Drazen JM;
    Lancet; 2004 Oct 23-29; 364(9444):1505-12. PubMed ID: 15500895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A controlled comparison of salbutamol and terbutaline inhaled by IPPV in asthmatic patients: a dose-response study.
    Bennis J; Svedmyr N
    Scand J Respir Dis Suppl; 1977; 101():113-7. PubMed ID: 343234
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma.
    Gibson GJ; Greenacre JK; König P; Conolly ME; Pride NB
    Br J Dis Chest; 1978 Jul; 72(3):199-206. PubMed ID: 212093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of controlled release salbutamol on nocturnal cough in asthma.
    Hoskyns EW; Thomson A; Decker E; Hutchins A; Simpson H
    Arch Dis Child; 1991 Oct; 66(10):1209-12. PubMed ID: 1953004
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intermittent and continuous salbutamol rotacaps inhalation in asthmatic patients.
    Patakas D; Maniki E; Tsara V; Daskalopoulou E
    Respiration; 1988; 54(3):174-8. PubMed ID: 3247516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and pharmacological study of a novel controlled release preparation of salbutamol.
    Milroy R; Carter R; Carlyle D; Boyd G
    Br J Clin Pharmacol; 1990 May; 29(5):578-80. PubMed ID: 2190630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma concentrations of salbutamol after an oral slow-release preparation.
    Maconochie JG; Fowler P
    Curr Med Res Opin; 1983; 8(9):634-9. PubMed ID: 6667627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of tolerance after continuous and prolonged oral administration of salbutamol to asthmatic patients.
    Bhatia SP; Davies HJ
    Br J Clin Pharmacol; 1975 Oct; 2(5):463-6. PubMed ID: 1233072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Controlled-release oral salbutamol and cardiac arrhythmias in asthmatic patients.
    Malerba M; Politi A; Filippi B; Boni E; Grassi V
    Chest; 1993 Sep; 104(3):987-8. PubMed ID: 8365344
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacokinetics of oral salbutamol controlled-release in Asian patients with asthma.
    Tan WC; Lee HS
    Eur J Clin Pharmacol; 1991; 41(5):495-6. PubMed ID: 1761082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bilayer Tablet Based Chronotherapeutics in the Management of Nocturnal Asthma: An Overview.
    Thakur S; Singh B; Mishra V; Yadav N; Giri N; Sharma P; Saini A; Garg LK
    Recent Pat Drug Deliv Formul; 2019; 13(2):74-82. PubMed ID: 30827275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence of cardiac arrhythmias in patients taking slow release salbutamol and slow release terbutaline for asthma.
    Al-Hillawi AH; Hayward R; Johnson NM
    Br Med J (Clin Res Ed); 1984 Feb; 288(6414):367. PubMed ID: 6419934
    [No Abstract]   [Full Text] [Related]  

  • 58. Controlled-release tablets of ethyl cellulose coated salbutamol sulphate microcapsules.
    Raghubanshi RS; Jayaswal SB; Singh J
    Pharmazie; 1991 Feb; 46(2):144-5. PubMed ID: 1852767
    [No Abstract]   [Full Text] [Related]  

  • 59. Tremor side effects of salbutamol, quantified by a laser pointer technique.
    Nizet TA; Broeders ME; Folgering HT
    Respir Med; 2004 Sep; 98(9):844-50. PubMed ID: 15338796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Underdiagnosis of asthma in the elderly.
    Banerjee DK; Lee GS; Malik SK; Daly S
    Br J Dis Chest; 1987 Jan; 81(1):23-9. PubMed ID: 3663486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.